
CVS Health Corporation CVS
$ 79.55
0.15%
Quarterly report 2025-Q2
added 07-31-2025
CVS Health Corporation Accounts Receivables 2011-2025 | CVS
Accounts receivable — is the amount of money owed to a company by other organizations, individuals, or the government. It arises when a company has already delivered goods, performed work, or provided services, but has not yet received payment for them.Examples of accounts receivable
- Customers have not paid invoices for delivered products
- An advance has been paid to a supplier, but goods have not yet been received
- Employees have not reported on accountable amounts
- The government must refund tax overpayments
- Outstanding loans issued
- Asset quality
Accounts receivable are part of current assets. But they are not cash — they are promises. Investors assess how realistic these promises are to be collected. The higher the share of overdue or doubtful receivables, the greater the risk of asset impairment. - Impact on cash flow
Even if a company shows a profit, the money can be "tied up" in receivables. This means profit does not turn into actual cash, and the company may face liquidity shortages. - Assessment of management efficiency
The following accounts receivable turnover ratios are commonly used:
Receivables turnover = Revenue / Average accounts receivable
(the higher — the better)
Days Sales Outstanding (DSO) = 365 / Turnover
(the fewer days — the faster customers pay)
If the DSO is constantly increasing — this is a red flag — customers are delaying payments, and money gets stuck in settlements.
Annual Accounts Receivables CVS Health Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 36.5 B | 35.2 B | 27.3 B | 24.4 B | 21.7 B | 19.6 B | 17.6 B | 13.2 B | 12.2 B | 11.9 B | 9.69 B | 8.73 B | 6.47 B | 6.05 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 36.5 B | 6.05 B | 17.9 B |
Quarterly Accounts Receivables CVS Health Corporation
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 40.7 B | 39.6 B | 36.5 B | 36.2 B | 32.4 B | 32.2 B | 35.2 B | 32.9 B | 29.5 B | 28.3 B | 27.3 B | 26.3 B | - | 26.5 B | 24.4 B | 25.3 B | 24.2 B | 23.9 B | 21.7 B | 21.7 B | 21.7 B | 21.7 B | 19.6 B | 19.6 B | 19.6 B | 19.6 B | 17.6 B | 17.6 B | 17.6 B | 17.6 B | 13.2 B | 13.2 B | 13.2 B | 13.2 B | 12.2 B | 12.2 B | 12.2 B | 12.2 B | 11.9 B | 11.9 B | 11.9 B | 11.9 B | 9.69 B | 9.69 B | 9.69 B | 9.69 B | 8.73 B | 8.73 B | 8.73 B | 8.73 B | 6.48 B | 6.47 B | 6.47 B | 6.47 B | 6.05 B | 6.05 B | 6.05 B | 6.05 B |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 40.7 B | 6.05 B | 18.1 B |
Accounts Receivables of other stocks in the Health care industry
| Issuer | Accounts Receivables | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Cigna Corporation
CI
|
24.2 B | $ 276.37 | 0.62 % | $ 75.7 B | ||
|
Humana
HUM
|
2.7 B | $ 273.95 | 2.12 % | $ 33 B | ||
|
Molina Healthcare
MOH
|
3.3 B | $ 166.33 | -1.28 % | $ 9.55 B | ||
|
UnitedHealth Group Inc.
UNH
|
22.4 B | $ 340.29 | -0.45 % | $ 313 B | ||
|
NovoCure Limited
NVCR
|
74.2 M | $ 13.02 | -2.29 % | $ 1.4 B |